Skip to main content
Equibles

SAMRATPH · SAMRAT PHARMACHEM LTD.

Use SAMRATPH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SAMRATPH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
260.40 INR +5.40 (+2.12%) At close · Nov 13
Rebalance outlook locked
Market Cap
804.56M INR
Shares
3.09M
Volume · Nov 13 682 Avg daily vol (3M) 1629

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close260.40 INR Open256.80 INR Day249.00–263.35 INR 52W close194.95–288.10 INR Avg vol 30d2K DataJan 2020–Nov 2026

Quarterly results

Revenue Net income Net loss
· 712.03M INR −3.99M INR '25 Q4 · 756.52M INR −2.29M INR '26 Q1 · 788.70M INR −5.87M INR '26 Q2 · 634.26M INR −4.59M INR '26 Q3 ▲0.8% 717.73M INR −20.36M INR '26 Q4 LATEST ▲5.4% 797.61M INR 8.76M INR '27 Q1

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 194.95 INR Now 260.40 INR · 70% Range high 288.10 INR
vs 200-day avg +14% vs 50-day avg +6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:SAMRATPH +2.2% +12.7% +15.5% -0.3% +14.6%

Exchange listing

Market
XBOM
Ticker
SAMRATPH
ISIN
INE103E01016
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.samratpharmachem.com/

Other listings of this company

No other verified listings are available.

Recent dividends

Ex-dividend dateAmount per share
2025-09-18 1.00 INR
2024-09-19 1.00 INR
2023-09-18 1.00 INR
2022-09-22 1.00 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.